GENEVA, Jan. 27 -- GLUETACS THERAPEUTICS (SHANGHAI) CO., LTD. (Room 101, Building 20, Lane 218, Haiji 6th Road, Lingang Special Area, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201306), 标新生物医药科技(上海)有限公司 (中国上海市浦东新区中国(上海)自由贸易试验区临港新片区海基六路218弄20号101室) filed a patent application (PCT/CN2024/105487) for "GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND" on Jul 15, 2024. With public...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.